Form 4: Avidity Biosciences Director Levin Exercises Options and Sells Shares

Director Arthur A. Levin exercised stock options and sold shares of Avidity Biosciences (RNA) on March 19, 2024.

Summary

• On March 19, 2024, Arthur A. Levin, a director of Avidity Biosciences, exercised stock options to acquire 5,000 shares of common stock at a price of $1.24 per share.
• Simultaneously, Levin sold 5,000 shares of Avidity Biosciences common stock at a weighted-average price of $23.9695, with individual sales ranging from $23.69 to $24.56.
• Following these transactions, Levin directly owns 14,830 shares of common stock and indirectly owns 273,872 shares through a family trust.
• Levin also holds options to purchase 38,323 shares of common stock.

Sentiment

Score: 5

Explanation: Neutral sentiment as it reflects routine insider trading activity. The director exercised options and sold shares, which doesn't necessarily indicate a positive or negative outlook.

Industry Context

This Form 4 filing indicates insider trading activity, which is common for company directors and officers. Monitoring such filings can provide insights into management's perspective on the company's valuation and future prospects.

Stakeholder Impact

• Shareholders may be interested in this transaction as it provides insight into a director's view of the company's stock value.
• The market may react to the sale of shares by a director, although the impact is likely to be minimal given the relatively small number of shares involved.

Key Dates